From Bio Co

From Bio Co Operating Cash Flow

The Operating Cash Flow of From Bio Co (377220.KQ) as of Oct 29, 2026 is -10.07 B KRW. In the previous year, Operating Cash Flow was -14.70 B KRW — a change of -31.48% (higher).

Operating Cash Flow

-10.07 BKRW

YoY

-31.48%

Last updated:

Operating Cash Flow of From Bio Co is 2025 -10.07 B KRW. Operating Cash Flow of From Bio Co was 2024 -14.70 B KRW. It decreases by -31.48% higher compared to the previous year.

The From Bio Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
5.68 B KRW
Jan 1, 2020
15.61 B KRW
Jan 1, 2021
-1.17 B KRW
Jan 1, 2022
-2.02 B KRW
Jan 1, 2023
-20.85 B KRW
Jan 1, 2024
-14.70 B KRW
Jan 1, 2025
-10.07 B KRW
The From Bio Co Operating Cash Flow history
YEAROperating Cash FlowYoY
-10.07 BKRW-31.48%
-14.70 BKRW-29.48%
-20.85 BKRW+930.20%
-2.02 BKRW+72.24%
-1.17 BKRW-107.53%
15.61 BKRW+174.88%
5.68 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

From Bio Co Stock analysis

What does From Bio Co do? From Bio Co., Ltd. generates revenue through the production and sale of health functional foods, including products targeting joint health, stomach health, eye health, and sleep health. The company also sells wild mango and other diet foods, alongside skincare items such as creams, shampoos, and soaps. Its primary customers are consumers seeking wellness solutions across multiple health categories, with a focus on natural and functional dietary supplements. The firm's product portfolio includes functional foods under specific health categories, with no additional brands or segments mentioned in the description. Revenue streams are derived directly from the sale of these products to end consumers, with no reference to third-party partnerships or distribution channels. The company's offerings are designed to address common health concerns through dietary and skincare solutions. From Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about From Bio Co stock

Operating Cash Flow of From Bio Co is -10.07 B KRW in 2025.

Operating Cash Flow of From Bio Co changed from -14.70 B KRW to -10.07 B KRW, representing a -31.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow From Bio Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's From Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — From Bio Co

All Key Metrics — From Bio Co